CapitalStars Updates: INDIAN BENCHMARKS

INDIAN BENCHMARKS  are likely to open on a cautious note as the global cues look mixed with SGX Nifty trading 12.50 points lower.

Headlines for the day:

• Aurobindo Pharma receives USFDA approval for anti-epileptic drug
• Biocon's arm Syngene International gets SEBI approval for IPO
• TVS Srichakra extends gain on ties up with France's Michelin

Trend in FII flows: The FIIs were net sellers of Rs  -604.86 Cr in the cash segment on Monday  while the DIIs were net buyers of Rs  650.47 Cr, as per the provisional figures released by the NSE.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. CapitalStars also aveliable on social network

• CapitalStars Twitter
• CapitalStars Linkedin
• CapitalStars Facebook

CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX.